Furthermore, vaccinated people were at lower risk of long-term breathing difficulties than unvaccinated individuals
Fluvoxamine Does Not Improve Time to Sustained Recovery in Mild COVID-19
No difference seen for fluvoxamine, placebo in composite outcome of hospitalization, urgent care visit, emergency department visit, death
Vaccine Coverage by Age 24 Months Unchanged During Pandemic
Coverage with combined seven vaccine series decreased for children living below federal poverty level, in rural areas
2020 to 2021 Saw No Change in Overall Fetal Mortality Rates
5 percent decline seen in rate for non-Hispanic Black women but no change for non-Hispanic White, Hispanic women
Overall Increase Seen in COVID-19 Vaccine Acceptance Globally
Vaccine hesitancy varied considerably; 12.1 percent of vaccinated individuals hesitant about booster doses
U.S. Mails Out Some COVID-19 Tests That Are About to Expire
Caution is advised about using expired tests
Pandemic Disrupted In-Person Mental Health Services
However, expansion of telehealth yielded net increase in care for major depressive disorder, anxiety, and adjustment disorder
Free Spike Antigen ID’d in Post-SARS-CoV-2 mRNA Vaccine Myocarditis
However, mRNA vaccine-induced immune responses did not differ for those who developed myocarditis and those who did not
Racial/Ethnic Variation Seen in COVID-19 Vaccination Status in Children
Non-Hispanic Asian children and adolescents have the highest vaccination coverage, followed by Hispanic/Latino children
VV116 Noninferior to Nirmatrelvir-Ritonavir for COVID-19
Noninferiority established with respect to time to sustained clinical recovery for adults at high risk for progression